AF Cohen - Concepedia

Author

AF Cohen

Centre for Human Drug Research

Also Known As

AF Cohen

Publications

584

Citations

H-Index

Concepts

All Affiliations

Centre for Human Drug Research Leiden University

About

AF Cohen is an author at Centre for Human Drug Research specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	279
2	Social Sciences	3	3	170
3	Anesthesia	2	2	84
4	Health Sciences	1	1	17
5	Health Policy	1	1	17

AF Cohen

Publications

415

Citations

H-Index

Page 1

	Year	Citations
Modelling of the concentration—effect relationship of THC on central nervous system parameters and heart rate — insight into its mechanisms of action and a tool for clinical research and development of cannabinoids Ashley Strougo, Lineke Zuurman, Christine Le Roy, Journal of Psychopharmacology PsychopharmacologyPharmacotherapyCannabinoid PharmacologyPhysiologically-based Pharmacokinetic ModelingSocial Sciences	2008	80
The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's syndrome). John Posner, AF Cohen, G. Land, British Journal of Clinical Pharmacology Plasma Elimination Half-lifeHealthy SubjectsUnconjugated HyperbilirubinaemiaLamotrigine EliminationMedicine	1989	70
Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects S. Haas, JMA van Gerven, Petra Hoever, Journal of Psychopharmacology Short Elimination Half-lifeNeuropsychologyHealthy SubjectsPharmacological StudyNeurophysiology	2009	62
Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green. PA Soons, Angela G. E. M. de Boer, AF Cohen, British Journal of Clinical Pharmacology	1991	40
Self‐selection for personality variables among healthy volunteers. MS Pieters, A. Jennekens‐Schinkel, AF Cohen British Journal of Clinical Pharmacology	1992	35
The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects M Liem-Moolenaar, RWM Zoethout, Peter de Boer, Journal of Psychopharmacology NeuropsychologyHealthy SubjectsPsychopharmacologyScopolamine ChallengeScopolamine-induced Impairments	2009	28
A cross‐over comparison of the anti‐clotting effects of three low molecular weight heparins and glycosaminoglycuronan. JC Stiekema, JM Van Griensven, TG Van Dinther, British Journal of Clinical Pharmacology	1993	24
The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay. AF Cohen, Ria Kroon, DD Breimer, British Journal of Clinical Pharmacology	1993	23
Cimetidine does not influence the metabolism of the H1‐receptor antagonist ebastine to its active metabolite carebastine. Jeroen van Rooij, René Bruno, JF Reinhoudt, British Journal of Clinical Pharmacology Drug SafetyMolecular PharmacologyBlood PressureCimetidine CoadministrationPharmacological Study	1993	22
Re-engineering the European Union Clinical Trials Directive MJH Kenter, AF Cohen The Lancet Health PolicyClinical Trial ManagementClinical TrialsRandomized Controlled TrialDrug Trial	2012	17

Page 1